アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/06/08 | 2,076 | 2,100 | 2,060 | 2,090 | +20 | +1% | 4,177,600 |
2022/06/07 | 2,048 | 2,093 | 2,035.5 | 2,070 | +21.5 | +1% | 2,976,500 |
2022/06/06 | 2,004.5 | 2,061.5 | 2,004.5 | 2,048.5 | +19 | +0.9% | 3,503,200 |
2022/06/03 | 2,036 | 2,048 | 2,008 | 2,029.5 | +12.5 | +0.6% | 4,241,900 |
2022/06/02 | 2,090.5 | 2,096 | 2,011 | 2,017 | -86 | -4.1% | 4,251,300 |
2022/06/01 | 2,101.5 | 2,113.5 | 2,087.5 | 2,103 | +40.5 | +2% | 5,022,100 |
2022/05/31 | 2,060 | 2,092 | 2,051 | 2,062.5 | +21 | +1% | 9,506,300 |
2022/05/30 | 2,030 | 2,061.5 | 2,017.5 | 2,041.5 | +20.5 | +1% | 8,568,200 |
2022/05/27 | 2,055 | 2,055 | 1,996 | 2,021 | -15 | -0.7% | 4,854,500 |
2022/05/26 | 2,020 | 2,049.5 | 2,020 | 2,036 | +34 | +1.7% | 5,073,200 |
2022/05/25 | 2,008 | 2,021 | 1,996 | 2,002 | +13 | +0.7% | 4,478,900 |
2022/05/24 | 1,990 | 1,998 | 1,973.5 | 1,989 | -4 | -0.2% | 2,924,000 |
2022/05/23 | 1,981.5 | 1,998 | 1,969.5 | 1,993 | +30.5 | +1.6% | 3,507,400 |
2022/05/20 | 1,958.5 | 1,975 | 1,934 | 1,962.5 | -0.5 | ±0% | 5,087,600 |
2022/05/19 | 1,974 | 1,975 | 1,948.5 | 1,963 | -29 | -1.5% | 4,356,700 |
2022/05/18 | 1,962 | 1,999.5 | 1,960.5 | 1,992 | +35.5 | +1.8% | 3,180,000 |
2022/05/17 | 1,957 | 1,976.5 | 1,941 | 1,956.5 | +0.5 | ±0% | 3,729,100 |
2022/05/16 | 1,986 | 2,008.5 | 1,945 | 1,956 | -3.5 | -0.2% | 2,750,600 |
2022/05/13 | 1,936.5 | 1,980 | 1,936 | 1,959.5 | +18 | +0.9% | 6,318,300 |
2022/05/12 | 1,942.5 | 1,947.5 | 1,916.5 | 1,941.5 | -14.5 | -0.7% | 3,722,900 |
2022/05/11 | 1,936.5 | 1,963 | 1,928.5 | 1,956 | +4 | +0.2% | 4,077,800 |
2022/05/10 | 1,931.5 | 1,960 | 1,922.5 | 1,952 | +31.5 | +1.6% | 4,446,400 |
2022/05/09 | 1,933 | 1,952 | 1,907.5 | 1,920.5 | -34 | -1.7% | 3,169,400 |
2022/05/06 | 1,974 | 1,978 | 1,923.5 | 1,954.5 | -5.5 | -0.3% | 5,153,300 |
2022/05/02 | 1,926.5 | 1,969 | 1,921 | 1,960 | -18 | -0.9% | 5,984,400 |
2022/04/28 | 1,944 | 1,978 | 1,912.5 | 1,978 | -6 | -0.3% | 7,690,300 |
2022/04/27 | 2,025 | 2,053 | 1,976 | 1,984 | -58 | -2.8% | 8,652,200 |
2022/04/26 | 2,020 | 2,049.5 | 2,020 | 2,042 | +6 | +0.3% | 3,614,100 |
2022/04/25 | 2,041.5 | 2,047 | 2,015 | 2,036 | -21.5 | -1% | 3,133,200 |
2022/04/22 | 2,059 | 2,079 | 2,045 | 2,057.5 | -20 | -1% | 3,293,600 |
2022/04/21 | 2,048.5 | 2,087.5 | 2,045 | 2,077.5 | +24.5 | +1.2% | 4,307,300 |
2022/04/20 | 2,040 | 2,062 | 2,030.5 | 2,053 | +19.5 | +1% | 3,233,600 |
2022/04/19 | 2,028.5 | 2,049 | 2,016.5 | 2,033.5 | -3.5 | -0.2% | 3,855,900 |
2022/04/18 | 2,062.5 | 2,070.5 | 2,023.5 | 2,037 | -35.5 | -1.7% | 2,826,600 |
2022/04/15 | 2,059 | 2,092.5 | 2,053 | 2,072.5 | -17.5 | -0.8% | 2,985,000 |
2022/04/14 | 2,071.5 | 2,103 | 2,061 | 2,090 | +13.5 | +0.7% | 4,624,100 |
2022/04/13 | 2,011 | 2,089 | 2,004.5 | 2,076.5 | +52 | +2.6% | 7,250,900 |
2022/04/12 | 2,073.5 | 2,076.5 | 2,011.5 | 2,024.5 | -76 | -3.6% | 6,672,900 |
2022/04/11 | 1,996 | 2,105 | 1,990.5 | 2,100.5 | +104.5 | +5.2% | 10,340,800 |
2022/04/08 | 2,038 | 2,063.5 | 1,981.5 | 1,996 | -12 | -0.6% | 10,077,800 |
2022/04/07 | 1,947.5 | 2,014 | 1,926 | 2,008 | +110 | +5.8% | 10,697,500 |
2022/04/06 | 1,881.5 | 1,906.5 | 1,872.5 | 1,898 | +22.5 | +1.2% | 5,311,600 |
2022/04/05 | 1,860 | 1,891 | 1,860 | 1,875.5 | -50.5 | -2.6% | 5,614,700 |
2022/04/04 | 1,885.5 | 1,935 | 1,875 | 1,926 | +72 | +3.9% | 5,559,300 |
2022/04/01 | 1,898.5 | 1,901.5 | 1,854 | 1,854 | -57 | -3% | 6,377,200 |
2022/03/31 | 1,937.5 | 1,950 | 1,909 | 1,911 | -42.5 | -2.2% | 6,009,100 |
2022/03/30 | 1,961 | 1,974 | 1,929.5 | 1,953.5 | -16 | -0.8% | 4,208,900 |
2022/03/29 | 1,964 | 1,979.5 | 1,949.5 | 1,969.5 | +24.5 | +1.3% | 5,393,400 |
2022/03/28 | 1,962 | 1,964.5 | 1,941 | 1,945 | -16 | -0.8% | 3,274,000 |
2022/03/25 | 1,975 | 1,977 | 1,941 | 1,961 | -10.5 | -0.5% | 3,621,000 |
651~
700
件表示中 / 3631件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 147,700円 | +18.5% | -96.0% | 5.01% | 188.87倍 | 1.73倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 412,000円 | +7.7% | +206.9% | 4.76% | 55.34倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 798,500円 | +14.4% | +120.8% | 1.50% | 17.87倍 | 1.64倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 214,400円 | +5.7% | +3.9% | 2.67% | 10.66倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 440,700円 | +1.7% | -2.9% | 3.63% | 28.92倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム